While Aura Biosciences Inc has overperformed by 1.55%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, AURA fell by -20.19%, with highs and lows ranging from $12.38 to $4.34, whereas the simple moving average fell by -14.82% in the last 200 days.
On May 28, 2025, H.C. Wainwright started tracking Aura Biosciences Inc (NASDAQ: AURA) recommending Buy. A report published by H.C. Wainwright on July 25, 2024, Initiated its previous ‘Buy’ rating for AURA. BTIG Research Initiated an Buy rating on April 17, 2023, and assigned a price target of $38. JMP Securities initiated its ‘Mkt Outperform’ rating for AURA, as published in its report on July 19, 2022.
Analysis of Aura Biosciences Inc (AURA)
Aura Biosciences Inc’s future performance can be predicted by a variety of well-rounded types of analysis and research, with equity being one of the most crucial ones. The goal here is to ensure that your current return on equity of -56.24% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 11.06, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
For any stock, average volume can be an extremely valuable indicator of volatility, and AURA is registering an average volume of 237.89K. On a monthly basis, the volatility of the stock is set at 6.35%, whereas on a weekly basis, it is put at 5.98%, with a gain of 4.29% over the past seven days. Furthermore, long-term investors anticipate a median target price of $21.20, showing growth from the present price of $6.56, which can serve as yet another indication of whether AURA is worth investing in or should be passed over.
How Do You Analyze Aura Biosciences Inc Shares?
Besides checking the fundamentals, you should also know how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 24.96%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 61.09% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
AURA shares are owned by institutional investors to the tune of 61.09% at present.
